A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion. - Yu, Meng; Lin, Ang; Baharom, Faezzah; Li, Shuijie; Legendre, Maureen; Covés-Datson, Evelyn; Sohlberg, Ebba; Schlisio, Susanne; Loré, Karin; Markovitz, David M.; Smed-Sörensen, Anna (PLoS Pathogens, 2025)